Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2890 (LINC02890) is a long intergenic non-coding RNA gene that produces a non-coding transcript longer than 200 nucleotides, without coding potential for a protein. LINC02890 belongs to the lincRNA class, distinguished by its location outside annotated protein-coding regions and by its lack of overlap with protein-coding genes. Members of the lincRNA family are known to regulate gene expression through mechanisms such as chromatin remodeling, RNA stabilization, enhancer-like activities, and modulation of neighboring gene transcription. However, specific biological roles and disease associations for LINC02890 have not yet been functionally validated.
Not applicable (no drugs known to target LINC02890)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2890 (LINC02890).